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a b s t r a c t
Here, we review the role of oxidative protein modiﬁcation as a signal for recognition and degradation of
proteins. It was clearly demonstrated that the ATP- and ubiquitin-independent 20S proteasome is playing
a key role in the selective removal of oxidized proteins. Furthermore, the current knowledge of the
substrate susceptibility on the degradation of oxidized proteins and the role of the immunoproteasome
will be highlighted.
& 2013 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Introduction
In the ﬁrst part of this series we described the principle
proteasomal structure and its regulatory complexes [1]. Here we
focus on the role of protein oxidation in the substrate recognition
of the proteasome.
Cellular metabolism is accompanied by constant formation of
free radicals and oxidants. Depending on the cell type, some 200
different reactive species can be found in humans [2], physiologi-
cal/pathophysiological conditions, cellular substrate turnover, spe-
cialization and the functional proteome, age and environmental
factors the cellular radical formation may vary in a broad range.
Reactive oxygen (ROS) and nitrogen species (RNS) have been
considered as the major cause of aging, aging associated cellular
dysfunctions, and a main factor in many pathologies. Though,
meanwhile it became clear that ROS are also integral mediators of
cellular adaption, summarized under the term redox signaling.
Nevertheless, ROS are able to oxidatively damage/modify cell
structures as proteins, lipids or nucleic acids. Due to the abun-
dance of proteins, a bulk of ROS-induced oxidative damage is
taken by them, interestingly predominantly by cytosolic proteins.
Usually, the nuclear compartment shows only very low amounts of
oxidatively modiﬁed proteins or aggregates of oxidized proteins,
even after phases of severe oxidative stress [3–5].
However, since the permanent oxidative modiﬁcation of
proteins is an inevitable by-product of metabolism in every living
cell, several different “counteracting” systems have evolved.
A few of them are specialized in the repair of oxidatively
damaged proteins, but their capacity is very limited: the only
two known amino acids that can be repaired in an enzymatic way
in mammalian cells are cysteine and methionine, while the bulk
of oxidative modiﬁcation is irreversible. Fig. 1 gives an overview
over the most common reversible and irreversible protein-
modiﬁcations. If proteins become oxidatively modiﬁed/damaged
in an irreversible way, cells need effective systems for recognition
and removing. For this purpose a cell provides different systems for
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degradation of proteins, as the lysosomal system, mitochondrial
proteases (mainly the Lon protease [6,7]), different calcium-
dependent proteases and the proteasomal system [8]. The multi-
catalytic 20S proteasome, an evolutionary very ancient system, has
been described in detail in the ﬁrst part of this series [1].
Proteasomes can be found in all three kingdoms of life: bacteria
(in the archaea), plants, and animals.
A large body of evidence demonstrated that the 20S protea-
some is the main proteolytic system removing oxidatively
damaged proteins [1,9–12]. In contrast to the degradation of
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Fig. 1. Typical ROS/RNS-mediated protein and side-chain modiﬁcations. This ﬁgure depicts some of the main reversible and irreversible protein modiﬁcations caused by
ROS/RNS. The upper part shows different modiﬁcations some proteins can undergo in cells exposed to oxidative stress. Some of them are reversible oxidative modiﬁcation
(green box), that can be reversed by the cellular enzymatic machinery (see text below); another reversible pathway is the modiﬁcation by cellular enzymes, that occurs in
response to oxidative stress (yellow box). These modiﬁcations can be induced by ROS/RNS directly or by enzymatic reactions in response to ROS/RNS or a shifted redox-state
of the cell, a common example for this is the so-called S-glutathionylation, mainly induced by oxidation of cysteine residues and reversed in an enzymatic way [23–25].
Another category is the formation of irreversible oxidative modiﬁcations by ROS/RNS that cannot be reversed by cellular enzymes (orange). Such proteins are usually
recognized and degraded by specialized cellular enzymatic systems [8,9,26–30]. The lower part of the ﬁgure lists oxidative protein modiﬁcation, classiﬁed by general
principles or speciﬁc amino acid side-chains reactions. Reversible modiﬁcations are mainly found in cysteine and methionine residues, the only two amino acids that can be
reduced/repaired by the cellular antioxidative enzymatic machinery. Methionine sulfoxide (MetSO) can be reduced by the methionine sulfoxide reductases Msr-A (speciﬁc
for the S-stereoisomer) and Msr-B (speciﬁc for the R-stereoisomer of MetSO); both of them (Msr-A/B) use thioredoxin (Th-(SH)2) as reducing elements; after this, Th-(S-S) is
reduced to Thr-(SH)2 again by the enzyme thioredoxin reductase in a NADPH-consuming way. The other amino acid residue very susceptible to ROS/RNS is cysteine.
Its oxidation causes in proteins intra- or intermolecular cross-links (disulﬁdes). Similar to MetSO, cysteine can be reduced by thioltransferases, that use either glutathione (GSH)
or reduced thioredoxin (Th-(SH)2) in order to reduce a disulﬁde (–S–S–) into two separate –SH-groups (sulfhydryls). Of the different stages of cysteine oxidation, only the
formation of the cysteinyl radical (protein-Cys-S) and oxidation to sulfenic acid (protein-Cys-SOH) is reversible, while oxidation to sulﬁnic and sulfonic acid is irreversible,
despite of a single known and highly specialized exception: sulﬁredoxin is actually able to reduce sulﬁnic acid (protein-Cys-SO2H) in peroxiredoxins in an ATP-consuming
reaction [31]. A loss of SH-groups may result in protein mis-/unfolding, inactivation (catalytic center), decreased antioxidative capacity, as well as the loss of speciﬁc
functions. The variation of irreversible protein modiﬁcations outnumber the reversible ones by far and have in common that they cannot be repaired/reduced by the
antioxidative machinery of the cell. Such general modiﬁcations (left description ﬁeld of the lower part of this ﬁgure) can be induced by attacks of highly reactive radicals like
hydroxyl, that are able to induce fragmentation of the protein, while attack on glycine seems to play a major role, as well as on proline, histidine and lysine [32]; furthermore,
histidine is important in the formation of covalent cross-links [33]. Other events are de- and transamination (of glutamine and asparagine residues) that even can occur in
a spontaneous way and does not have to be mediated/induced by ROS/RNS [34]. Furthermore, the formation of so-called advanced glycation end products (AGE's) [20,35,36]
has been shown: Nε-carboxymethyllysine (CML) and Nε-carboxyethyllysine (CEL), as well as different glyoxal-lysine dimers (GOLDs) and methylglyoxal-lysine dimers
(MOLDs) or pentosidine [37]. These AGEs are products of sugars and proteins, forming glycated proteins that may occur also from methylglyoxal, a potent glycating agent
derived from trioses. Very prone to oxidative modiﬁcations are also the lipids in a cell. After ROS/RNS-mediated damage, amongst others highly reactive aldehydes are
formed, that are able to react with proteins. The main reactive aldehydes are 4-hydroxy-2,3-nonenal (HNE, one of the most abundant products of lipid peroxidation, a
bifunctional aldehyde, able to covalently cross-link proteins via reaction with either cysteine, lysine or histidine, followed by reaction with a lysine residue of another
protein) [38], 4-hydroxyhexenal (HHE), malondialdehyde (MDA, forms Nε-malondialdehydelysine with lysine residues or the ﬂuorescent adduct 1,4-dihydropyridine-3,
5-dicarbaldehydes) [39]. The aldehydes glyoxal and acrolein react mainly with lysine, arginine, and histidine. The according end products of the mentioned reactions are
referred to in the literature as “advanced lipid peroxidation end products” (ALEs)[37]. A typical step in the fragmentation of the protein backbone is the formation of an
alkoxyl radical within the protein, that can decay either via the so-called diamide or α-amination pathways [40]. The irreversible oxidative modiﬁcations of speciﬁc residues
show a large variety, but in biological systems several predominant modiﬁcations can be found some of them listed in the right description ﬁeld of the lower part of this
ﬁgure. In cells, the formation of 3-nitrotyrosine is mainly a hint to the presence of peroxynitrite (ONOO), and thus the immunochemical detection of 3-nitrotyrosine
became a quantitative and qualitative marker for ONOO-mediated protein oxidation [41]. Dityrosines are mainly formed via the reaction of two tyrosyl radicals [42]. Those
can be formed by the reaction of tyrosine side chains with hydroxyl radicals, hypochlorite or peroxynitrite [43]. Furthermore, hydroxyl radical mediated hydroxylation of
phenylalanine, tyrosine and tryptophan plays a major role as well as comparable reactions of histidine, forming 2-oxohistidine [44]. Protein carbonyls [3,5] are the most
abundant oxidative protein modiﬁcation – their rate of formation is about 10-times higher than for any other oxidative protein modiﬁcation. Protein carbonyls are mainly
formed by oxidation of valine, leucine, isoleucine, lysine, glutamine, arginine, and proline side chains. Due to their high occurrence and establishment of easy to handle
methods, protein carbonyls are the most often used quantitative marker of oxidative proteinmodiﬁcation. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)
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native proteins, the degradation of oxidatively damaged proteins
does neither require the presence of ATP nor the polyubiquitina-
tion of the substrate, since an inhibition of the ubiquitinating
system did only reveal any impact on the degradation of oxidized
proteins as shown in Fig. 2. In fact, the 26S proteasome turned
out to be very poor at degrading oxidatively damaged proteins
[13]. Especially in phases of oxidative stress, the 26S proteasome
disassembles (release of 19S) as well as the ubiquitinating system
(especially E1- and E2-enzymes [14]) become deactivated already
at peroxynitrite, hypochlorite or H2O2 concentrations that are
about one magnitude lower than the concentrations needed to
inactivate the uncapped 20S proteasome [15]. Oxidative damage/
modiﬁcation is not really a deﬁned state or structure, but a slight
transition from a natively folded and fully functional protein to a
massively oxidized and covalently cross-linked state as depicted
in Fig. 3. Thus, this transition is not deﬁned stages by discreet
stages of oxidation. Therefore, certain criteria as the exposure
of hydrophobic structures that are normally buried inside
of a natively folded protein render an oxidatively damaged
protein susceptible to proteolytic degradation mediated by the
20S proteasome. Those exposed hydrophobic structures are pro-
posed to be responsible for proteasomal substrate recognition [16]. In
any case, the transition from a natively folded protein to a slightly
oxidized unfolded proteasomal substrate is often not a “one hit”
event, but has to be considered as the accumulation of several
single events.
Proteolytic degradation of an oxidized protein has different
aspects in the protection of the normal function of a cell.
Furthermost, is the avoidance of the formation of highly oxidized,
cross-linked protein aggregates, that may grow [17,18] become
further oxidized and covalently cross-linked. Such aggregates are
largely resistant to enzymatic degradation. Therefore, it is of key
importance to reduce the amount of oxidatively damaged pro-
teins after a stress event. Several regulatory events, as the release
of 20S proteasome by disintegration of the 26S proteasome and
the release of its regulators [19] and the induction of the
immunoproteasome, are the consequence of oxidative stress.
Interestingly an induction of the immunoproteasomal and 11S
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Fig. 2. Degradation of oxidized proteins is mainly mediated by the 20S proteasome. Panel A shows the effect of proteasomal inhibition on the degradation of oxidized
proteins. If cells are exposed to ROS/RNS (time of exposure highlighted in gray) a dramatic increase in the formation of oxidatively modiﬁed proteins takes place. These
oxidized proteins (here measured as protein carbonyls) have to be recognized and degraded in order to maintain the functionality of the cell. According to experimental
results, 80%–90% of all oxidatively damaged proteins are degraded via the 20S proteasomal pathway in an ATP-independent way [1,45–47]. Consequently, if the proteasome
is inhibited such oxidized proteins are not removed from the protein pool (red dashed line) [5]. Experimental data show, that the 20S proteasome is a very effective system
that reduced the amount of protein carbonyls in a cell within several hours to the level found in unexposed/unstressed cells (blue continuous line) [5,41]. If the 20S
proteasome is inhibited or knocked down by siRNA or Antisense nucleotides (red dashed line), the amount of protein carbonyls might still decrease over time, but at a much
lower rate, since the other cellular systems (for example the large diversity of lysosomal cathepsins) might be capable of degrading oxidized proteins, too, but show a much
lower performance, or the proteasomal inhibition is not complete. Thus, proteasomal inhibition, a decrease of proteasomal activity or the loss of proteasomes promotes the
accumulation of oxidized proteins. Panel B displays the contribution of the 26S proteasome or of the ubiquitination to the degradation of oxidized proteins. The 26S
proteasome might be blocked by siRNA and ubiquitination by the usage of conditionally ubiquitin deﬁcient cell lines [48,49]. After an E1-enzyme inactivation in such
conditionally ubiquitin deﬁcient cell lines, the amount of substrate polyubiquitination and thus labeling for 26S proteasomal degradation [1] signiﬁcantly decreases. Neither
of these modulations shows any signiﬁcant impact on the degradation of oxidized proteins. In this panel the theoretical proteolytic response of cells to a given ROS
concentration (here hydrogen peroxide) is demonstrated [12,15,48,50,51]. Elimination of the 26S proteasome or of the ubiquitination capacities do not have any inﬂuence on
this response. Taken together, this demonstrates that the 20S proteasome is the main system removing oxidized proteins from the cellular protein pool, and that oxidized
proteins do not have to be polyubiquitinylated in order to be degraded. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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subunits was observed after exposure to modiﬁed proteins or
oxidative stress [20,21]. Most interestingly, the immunoprotea-
some in combination with the 11S do have a higher activity
towards the oxidatively modiﬁed proteins (Fig. 4) and degrade
them with a higher efﬁciency. Since the induction of the immu-
noproteasome is fast compared with the turnover of the consti-
tutive proteasome [22], the immunoproteasomal form might
signiﬁcantly contribute to the degradation of oxidized proteins.
Therefore, this form of the proteasome is not only involved in
antigen presentation (hence the name ‘immunoporteasome’), but
seems to be involved in several cellular processes as an inducible
proteasomal form.
Summary
The efﬁcient degradation and removal of oxidized proteins is an
absolute requirement for the maintenance of the cellular metabo-
lism. It was demonstrated that the 20S proteasome is in an ATP-
and ubiquitin-independent way responsible for the degradation of
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Fig. 3. Increasing levels of oxidative protein damage affects the proteasomal degradation. The upper part of this ﬁgure shows the continuum of oxidative protein damage and
the resulting modiﬁcation and unfolding (according to Grune et al. [16]). Important to note, that oxidative modiﬁcation of a protein is a continuous process covering a very
broad range of successively increasing damage. An undamaged, natively folded protein (shown on the left in the upper row of images) is usually not recognized as a substrate
by the 20S proteasome. After slight oxidative damage a protein might show only insigniﬁcant changes in folding or activity. Here the solubility of the protein increases due to
additional charges that are brought in by oxidation. After further oxidative damage, hydrophobic sequences, normally buried in the inside of the protein are exposed more
and more to its surface and thus the aqueous environment (third image from the left). The damage-induced conformational change causes signiﬁcant loss of activity until the
protein is completely unfolded (fourth image from the left). Such proteins are ideal substrates for proteasomal degradation and most of those proteins are actually
recognized and removed via the 20S proteasomal pathway. However, the exposure of hydrophobic moieties to the protein surface holds the risk of a thermodynamically
driven protein aggregate formation. So initial aggregate formation is mainly driven by thermodynamics: the exposed hydrophobic sequences of the damaged proteins tend to
form clusters in order to minimize their interaction with the aqueous environment. These aggregates can still decompose again and be degraded as single unfolded proteins
mainly by the 20S proteasome. Here, chaperones might play a role, but this is still not demonstrated conclusively. Though, under oxidizing conditions the probability of
further protein oxidation and thus covalent cross-linking of the aggregated proteins increases. Once they are covalently cross-linked, they become resistant to (proteasomal)
proteolytic degradation. Such material has been shown to be resistant even to the most unspeciﬁc proteases [17]. Such a cross-linking might take place by direct protein–
protein interaction, e.g. tyrosine radicals and dityrosine formation or protein carbonyl and amino groups via a Schiff's-base formation. Furthermore, this cross-linking may be
facilitated by products of lipid-peroxidation, mainly bifunctional aldehydes like MDA or HNE. Heavily cross-linked protein aggregates may show an autoﬂuorescence that
may cover a very broad spectrum of the visible range. One of the few already identiﬁed ﬂuorescent structures is the pyridinium bisretinoid A2E, also a secondary product of
lipid peroxidation [52] that can be excited using an Argon laser (458 nm) [53]; further structures are 1,4-dihydropyridine, that results from the reaction of MDA with glycine
[54–56] as well as 2-hydroxy-3-imino-1,2-dihydropyrrol derivatives that result from the cyclization of lysine-HNE Michael adducts [57]. This heavily oxidized material,
containing both lipids and proteins, as well as low amounts of sugars is termed in the literature as “lipofuscin” [17,18,58–62]. Lipofuscin accumulates during aging, especially
in postmitotic aging cells. However, lipofuscin can be formed with an increased rate during different pathologies, termed as “lipofuscinoses” or “ceroid-lipofuscinoses”
[63,64]. These protein aggregates can incorporate redox-active transition metals (in mammalian cells mainly Fe2þ) [45], thus catalyzing radical formation via Fenton-
reaction, again increasing the rate of protein oxidation and lipofuscin-formation [59]. Interestingly, lipofuscin has been shown to be a potent proteasomal inhibitor [17],
Lipofuscin, the long-term product of oxidative stress, accumulates mainly in the lysosomal system, while only a very low amount (about 1%) is found free in the cytosol [18],
where it may interact with the proteasomal system, slowing down the degradation of lipofuscin-precursor-material. The lower part of the ﬁgure summarizes the different
effects of the exposure-time or the amount of oxidative stress applied to a cells on the proteolytic response. Curve 1 shows the amount of oxidized proteins that are
accessible for proteasomal degradation. Over time or with increasing ROS/RNS-concentration this amount ﬁrst increases due to a rising number of damaged proteins in the
cell, but then decreases again, due to the rising amount of non-degradable covalently-cross-linked material formed, that is very resistant to proteolytic attacks. (compare to
Fig. 2B). Curve 2 depicts this increasing amount of protein aggregate formation that decreases the amount of damaged proteins accessible to proteasomal degradation shown
in Curve 1.
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oxidized proteins. Furthermore, the substrate susceptibility is depen-
dent on the degree of its oxidation. Interestingly, lately an involvement
of the immunoproteasome and the 11S proteasomal regulator was
proposed to play a role in the degradation of oxidized proteins.
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